OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - IMMUNOMEDICS INC ownership

Back to all holdings Add to watchlist

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Links
Filings
External links
Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$118,381,000,000
+4901.3%
1,392,226
+1292.2%
3.01%
+6297.9%
Q2 2018$2,367,000,000–100,000–0.05%–
 Download
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders